| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/05/2005 | EP1492568A1 Cancer treatment method comprising administration of an erb-family inhibitor and a raf and/or ras inhibitor |
| 01/05/2005 | EP1492539A1 Statin therapy for enhancing cognitive maintenance |
| 01/05/2005 | EP1492537A1 Morpholine derivatives with a substituted acetamide group in the 2-position for use as ccr-3 antagonists for the treatment of inflammatory diseases |
| 01/05/2005 | EP1492534A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 01/05/2005 | EP1492526A2 Improved prodrugs of cc-1065 analogs |
| 01/05/2005 | EP0957914B1 Formulation of 5-ht agonists |
| 01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 01/05/2005 | CN1561341A Hydrolysis of [R(R*, R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 01/05/2005 | CN1561334A Indole derivatives as COXII inhibitors |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561212A Benzimidazolidinone derivatives as muscarinic agents |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1560035A 5-hydroxylic indole-3-carboxylic ester kind derivantion |
| 01/05/2005 | CN1183111C Cycloalkano-indole and cycloalkane-azaindole derivatives, process for their preparation and pharmaceutical commposition containing the same |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/04/2005 | US6838484 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor |
| 01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 01/04/2005 | US6838461 Psychological disorders; schizophrenia; Alzheimer's disease; Parkinson's disease; Huntington's disease; cardiovascular disorders; hypotensive agents; side effect reduction |
| 01/04/2005 | US6838415 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 01/04/2005 | CA2293834C Substituted naphthopyrans |
| 12/30/2004 | US20040266861 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
| 12/30/2004 | US20040266855 Effective against Src family; cancer, osteoporosis |
| 12/30/2004 | US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury |
| 12/30/2004 | US20040266789 Substituted amino carboxylic acids |
| 12/30/2004 | US20040266788 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatase |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 12/30/2004 | US20040265985 Such as 1S,4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene via N-acetylamino-alcohol hydrolase isolated from Rhodococcus, Gordona, Arthrobacter, Alcaligenes, Agrobacterium/Rhizobium, Bacillus, Pseudomonas or Alcaligenes/Bordetella |
| 12/30/2004 | US20040262576 such as tris(2-phenylpyridine)iridium which luminesce when voltage is applied; improved electroluminescent efficiency |
| 12/29/2004 | WO2004113453A1 Crystalline nonsolvated polymethine compound |
| 12/29/2004 | WO2004113394A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 12/29/2004 | WO2004113301A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 12/29/2004 | WO2004113296A1 A process for preparation of 1-[9h-carbazol-4-yloxy]- 3-[{2-(2-(-(methoxy)phenoxy)-ethyl}-amino]-propan-2-ol |
| 12/29/2004 | WO2004113295A1 Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof |
| 12/29/2004 | WO2004113293A1 Novel crystalline forms of perindopril erbumine |
| 12/29/2004 | WO2004113292A2 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 12/29/2004 | WO2004113291A2 Fluvastatin sodium crystal forms xiv, lxxiii,lxxix, lxxx and lxxxvii, processes for preparing them, compositions containing them and methods of using them |
| 12/29/2004 | WO2004113270A2 Propionic acid derivatives useful in the treatment of lipid disorders |
| 12/29/2004 | WO2004112718A2 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 12/29/2004 | WO2004085396A8 Preventive or therapeutic agent for ischemia/reperfusion injury, organ preservative, and screening method |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | WO2003045392A8 Use of n-(indolcarbonyl-)piperazine derivatives |
| 12/29/2004 | EP1491524A2 Selective androgen receptor modulators and methods of use thereof |
| 12/29/2004 | EP1491353A1 Optical recording media and dipyrromethene-metal chelate compounds |
| 12/29/2004 | EP1491206A1 Induction method for cell differentiation |
| 12/29/2004 | EP1490353A1 Method for manufacture of sertindole |
| 12/29/2004 | EP1490334A1 Phthalimido derivatives as inhibitors of monoamine oxidase b |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1425577A4 Apparatuses and methods for creating and testing pre-formulations and systems for same |
| 12/29/2004 | EP1226138B1 Fab i inhibitors |
| 12/29/2004 | EP1225882A4 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 12/29/2004 | EP1206442A4 Substituted chiral allosteric hemoglobin modifiers |
| 12/29/2004 | EP1135123B1 Use of isatin derivatives as ion channel activating agents |
| 12/29/2004 | EP1032560B1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate |
| 12/29/2004 | EP0869958B1 Novel indole-2,3-dione-3-oxime derivatives |
| 12/29/2004 | CN1558900A Pseudopolymorphic forms of carvedilol |
| 12/29/2004 | CN1558899A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 12/29/2004 | CN1558897A Antidiabetic agents |
| 12/29/2004 | CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/29/2004 | CN1182116C Mutilin derivatives and their use as antibacterials |
| 12/29/2004 | CN1182103C Novel ethylamine derivatives |
| 12/29/2004 | CA2613021A1 Fluvastatin sodium crystal form lxxx, processes for preparing, compositions and methods of using |
| 12/29/2004 | CA2613013A1 Fluvastatin sodium crystal form lxxiii, processes for preparing, compositions and methods of using |
| 12/29/2004 | CA2610635A1 Fluvastatin sodium crystal form lxxxvii, processes for preparing, compositions and methods of using |
| 12/29/2004 | CA2610633A1 Fluvastatin sodium crystal form lxxix, processes for preparing, compositions and methods of using |
| 12/29/2004 | CA2529859A1 Fluvastatin sodium crystal forms xiv, lxxiii ,lxxix, lxxx and lxxxvii, processes for preparing them, compositions containing them and methods of using them |
| 12/29/2004 | CA2529820A1 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 12/29/2004 | CA2529761A1 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 12/29/2004 | CA2528234A1 Propionic acid derivatives useful in the treatment of lipid disorders |
| 12/28/2004 | US6835843 Amidation, deprotected by catalytic hydrogenation, salt formation with tributylamine |
| 12/28/2004 | US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 12/28/2004 | US6835744 3,3-substituted indoline derivatives |
| 12/28/2004 | US6835729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 12/28/2004 | US6835727 Bone disorders; osteoporosis; rheumatic diseases |
| 12/28/2004 | US6835725 Cyanine dye containing heterocylic rings; satisfies light stability, favorable signal/noise rato, damage free application to the substrate material, use in the information layer in a write-once optical data carrier |
| 12/28/2004 | US6835712 Compounds |
| 12/28/2004 | US6835513 An organophotoreceptor comprising: (a) a charge transport compound having the formula carbazole compound dispersion of colorant particles in an organic liquid and charge transport compound having the formula of carbazole compound |
| 12/28/2004 | CA2281426C Substituted indole compounds as anti-inflammatory and analgesic agents |
| 12/28/2004 | CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives |
| 12/23/2004 | WO2004111193A2 Prodrugs of mitotic kinesin inhibitors |
| 12/23/2004 | WO2004111039A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 12/23/2004 | WO2004110999A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 12/23/2004 | WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | WO2004110983A2 New benzamides as pparϒ modulators |
| 12/23/2004 | WO2004110436A1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/23/2004 | WO2004110149A1 Use of isoindolinone derivatives as insecticides |
| 12/23/2004 | WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/23/2004 | WO2004099138A3 Process for the preparation of perindopril |
| 12/23/2004 | WO2004091482A3 M3 muscarinic acetylcholine receptor antagonists |
| 12/23/2004 | WO2004087048A3 Benzamide modulators of metabotropic glutamate receptors |
| 12/23/2004 | WO2004085392A8 Melatonin derivatives and their use for treating neurological dysfunctions |
| 12/23/2004 | WO2004064771A3 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents |
| 12/23/2004 | WO2003091689A3 Bis-transition-metal-chelate-probes |
| 12/23/2004 | US20040259939 Dissolving and precipitation a solution of citalopram in acid with solvent, adding base to liberate free base. |
| 12/23/2004 | US20040259919 for the treatment of diabetes, hyperglycemia, hypoglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, eating disorders, and nervous system disorders |
| 12/23/2004 | US20040259917 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 12/23/2004 | US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example |